LabCompass

Anita C. Bellail

Biochemistry, Genetics and Molecular Biology · Indiana University

OpenAlex
Established · publishing since 2000Rising activity
Cell death mechanisms and regulationinterferon and immune responsesUbiquitin and proteasome pathwaysCancer-related Molecular PathwaysCancer, Hypoxia, and Metabolism

Publications

55

Citations

3,772

Est. group size

—

Recurring co-author estimate

Active years

26

Publishing since 2000

Research summary
AI-generated

Anita C. Bellail studies the molecular pathways that control whether cancer cells live or die, with a focus on brain tumors (glioblastoma) and colorectal cancer. A major theme is the use of small-molecule 'degrader' drugs that trigger the cell's own machinery to break down disease-driving proteins, aiming to develop new cancer therapies. The work also touches on protein degradation in Alzheimer's disease.

Programmed cell death and apoptosis regulationProtein tagging and degradation (ubiquitin/SUMO pathways)Targeted protein degrader drugs for cancerGlioblastoma (brain tumor) biologyTumor immune signaling

Publication activity has been irregular, with several inactive years followed by a notable spike in 2023.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

Funding
Public award records

Current awards run through June 2027 — about under a year of funding on record from today. Awards are often renewed, so this is what is currently public, not a forecast.

  • ActiveNIH R01CA266699through Jun 2027 · $357k awarded

    Targeting SUMO1 degradation for advanced colon cancer therapy

Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.

In context
Among 1,668 established Biochemistry, Genetics and Molecular Biology PIs within our index
Citations: 3,772cohort median 3,422
h-index: 22cohort median 27
Publications / year (recent): 2.4cohort median 4.8

Typically publishes in teams of ~11 · 12% small-team papers (≤3 authors) · across 6 venues

Publication cadence
Publications per year over the last 10 years — averaging 2.4/year recently
2017: 1 publication171819202021: 3 publications21222023: 11 publications1123242025: 1 publication2526
Collaborators per year
Distinct co-authors at Indiana University each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
2017: 0 collaborators at the same institution2018: 0 collaborators at the same institution2019: 0 collaborators at the same institution2020: 0 collaborators at the same institution2021: 0 collaborators at the same institution2022: 0 collaborators at the same institution2023: 4 collaborators at the same institution2024: 0 collaborators at the same institution2025: 3 collaborators at the same institution1719212325
Recent publications
Publishes in
  • Molecular Carcinogenesis×2
  • bioRxiv (Cold Spring Harbor Laboratory)×2
  • Science Translational Medicine×1
  • Brain Pathology×1
  • Science Advances×1
Similar researchers
By research-topic overlap
  • Colin S. Duckett

    Biochemistry, Genetics and Molecular Biology · University of Michigan

  • Zaneta Nikolovska‐Coleska

    Biochemistry, Genetics and Molecular Biology · University of Michigan

  • Çağrı Bodur

    Biochemistry, Genetics and Molecular Biology · University of Michigan

  • Ahmed S.A. Mady

    Biochemistry, Genetics and Molecular Biology · University of Michigan

  • Jennifer Fox

    Biochemistry, Genetics and Molecular Biology · University of Michigan

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 27, 2026.

Claim or correct this profile